These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 21659322

  • 41. Correlation between PET/CT findings and pathological features of mediastinal lymph nodes in non-small cell lung cancer.
    Li X, Zheng X, Cao Y, Wang Y, Fan X, Xu W.
    Minerva Med; 2022 Jun; 113(3):586-588. PubMed ID: 33881280
    [No Abstract] [Full Text] [Related]

  • 42. 18F-FDG PET definition of gross tumor volume for radiotherapy of lung cancer: is the tumor uptake value-based approach appropriate for lymph node delineation?
    Rodríguez N, Sanz X, Trampal C, Foro P, Reig A, Lacruz M, Membrive I, Lozano J, Quera J, Algara M.
    Int J Radiat Oncol Biol Phys; 2010 Nov 01; 78(3):659-66. PubMed ID: 20133071
    [Abstract] [Full Text] [Related]

  • 43. [Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer].
    Hu M, Yu JM, Liu NB, Liu LP, Guo HB, Yang GR, Zhang PL, Xu XQ.
    Zhonghua Zhong Liu Za Zhi; 2008 Apr 01; 30(4):306-9. PubMed ID: 18788639
    [Abstract] [Full Text] [Related]

  • 44. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
    Miyasaka Y, Suzuki K, Takamochi K, Matsunaga T, Oh S.
    Eur J Cardiothorac Surg; 2013 Jul 01; 44(1):83-7. PubMed ID: 23233074
    [Abstract] [Full Text] [Related]

  • 45. 18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study.
    Higashi K, Ito K, Hiramatsu Y, Ishikawa T, Sakuma T, Matsunari I, Kuga G, Miura K, Higuchi T, Tonami H, Yamamoto I.
    J Nucl Med; 2005 Feb 01; 46(2):267-73. PubMed ID: 15695786
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Significance of a new fluorodeoxyglucose-positive lesion on restaging positron emission tomography/computed tomography after induction therapy for non-small-cell lung cancer.
    Collaud S, Lardinois D, Tischler V, Steinert HC, Stahel R, Weder W.
    Eur J Cardiothorac Surg; 2012 Mar 01; 41(3):612-6. PubMed ID: 22219415
    [Abstract] [Full Text] [Related]

  • 48. [Value of (18)F-FDG PET-CT in the preoperative N staging of non-small cell lung cancer].
    Li M, Wu N, Liang Y, Zheng R, Liu Y, Zhang WJ, Zhao P.
    Zhonghua Zhong Liu Za Zhi; 2009 Apr 01; 31(4):288-92. PubMed ID: 19615286
    [Abstract] [Full Text] [Related]

  • 49. The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis.
    de Langen AJ, Raijmakers P, Riphagen I, Paul MA, Hoekstra OS.
    Eur J Cardiothorac Surg; 2006 Jan 01; 29(1):26-9. PubMed ID: 16337397
    [Abstract] [Full Text] [Related]

  • 50. [Clinical value of computed tomography and fluorine-18 fluorodeoxyglucose positron remission tomography in diagnosis of mediastinal metastasis of non small cell lung cancer].
    Zhi XY, Liu BD, Xu QS, Zhang Y, Su L, Wang HR, Hu M.
    Zhonghua Yi Xue Za Zhi; 2005 Aug 03; 85(29):2026-9. PubMed ID: 16313793
    [Abstract] [Full Text] [Related]

  • 51. Intramedullary metastasis detected with 18F FDG-PET/CT.
    Sari O, Kaya B, Kara Gedik G, Ozcan Kara P, Varoglu E.
    Rev Esp Med Nucl Imagen Mol; 2012 Sep 03; 31(5):299-300. PubMed ID: 23067538
    [No Abstract] [Full Text] [Related]

  • 52. Contrast enhanced CT versus integrated PET-CT in pre-operative nodal staging of non-small cell lung cancer.
    Ceylan N, Doğan S, Kocaçelebi K, Savaş R, Çakan A, Çağrici U.
    Diagn Interv Radiol; 2012 Sep 03; 18(5):435-40. PubMed ID: 22374706
    [Abstract] [Full Text] [Related]

  • 53. FDG-PET in staging lung cancer: how does it change the algorithm?
    Verhagen AF, Bootsma GP, Tjan-Heijnen VC, van der Wilt GJ, Cox AL, Brouwer MH, Corstens FH, Oyen WJ.
    Lung Cancer; 2004 May 03; 44(2):175-81. PubMed ID: 15084382
    [Abstract] [Full Text] [Related]

  • 54. 18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer.
    Laking G, Price P.
    Thorax; 2001 Sep 03; 56 Suppl 2(Suppl 2):ii38-44. PubMed ID: 11514705
    [No Abstract] [Full Text] [Related]

  • 55. Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer.
    Reed CE, Harpole DH, Posther KE, Woolson SL, Downey RJ, Meyers BF, Heelan RT, MacApinlac HA, Jung SH, Silvestri GA, Siegel BA, Rusch VW, American College of Surgeons Oncology Group Z0050 trial.
    J Thorac Cardiovasc Surg; 2003 Dec 03; 126(6):1943-51. PubMed ID: 14688710
    [Abstract] [Full Text] [Related]

  • 56. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study.
    De Leyn P, Stroobants S, De Wever W, Lerut T, Coosemans W, Decker G, Nafteux P, Van Raemdonck D, Mortelmans L, Nackaerts K, Vansteenkiste J.
    J Clin Oncol; 2006 Jul 20; 24(21):3333-9. PubMed ID: 16849747
    [Abstract] [Full Text] [Related]

  • 57. Standard uptake value predicts survival in non-small cell lung cancer.
    Okereke IC, Gangadharan SP, Kent MS, Nicotera SP, Shen C, DeCamp MM.
    Ann Thorac Surg; 2009 Sep 20; 88(3):911-5; discussion 915-6. PubMed ID: 19699919
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Targeted lymph node biopsy in mediastinoscopy using 3D FDG-PET/CT movies: a feasibility study.
    Siepel FJ, de Bruin WI, van Duyn EB, Steenvoorde P, Wagenaar NR, Slump CH, van Dalen JA.
    Nucl Med Commun; 2012 Apr 20; 33(4):439-44. PubMed ID: 22311052
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.